Edition:
United Kingdom

Sophiris Bio Inc (SPHS.OQ)

SPHS.OQ on NASDAQ Stock Exchange Capital Market

2.06USD
14 Dec 2018
Change (% chg)

$-0.09 (-4.19%)
Prev Close
$2.15
Open
$2.12
Day's High
$2.15
Day's Low
$2.06
Volume
21,234
Avg. Vol
43,782
52-wk High
$4.04
52-wk Low
$1.72

Chart for

About

Sophiris Bio Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing products for the treatment of urological diseases. The Company is developing topsalysin (PRX302) as a treatment for the lower urinary tract symptoms of benign prostatic hyperplasia (BPH) commonly referred to as an enlarged... (more)

Overall

Beta: 2.10
Market Cap(Mil.): $70.63
Shares Outstanding(Mil.): 30.11
Dividend: --
Yield (%): --

Financials

  SPHS.OQ Industry Sector
P/E (TTM): -- 31.13 34.39
EPS (TTM): -0.26 -- --
ROI: -47.03 15.55 14.96
ROE: -97.97 16.92 16.52

SNB still sees correction risk in Swiss real estate market

ZURICH, Sept 20 The Swiss National Bank (SNB) again warned that Swiss mortgage and real estate markets could tumble, pointing to continued increases in banks' mortgage lending and a rise in housing prices amidst growing vacancies as persistent imbalances.

20 Sep 2018

Earnings vs. Estimates